(Rs. in Million) |
| Quarter ended | Year to Date | Year ended | |||||||
| 202306 | 202206 | % Var | 202306 | 202206 | % Var | 202303 | 202203 | % Var | |
| Sales | 54373.00 | 36306.00 | 49.76 | 54373.00 | 36306.00 | 49.76 | 169625.00 | 144052.00 | 17.75 |
| Other Income | 2336.00 | 4034.00 | -42.09 | 2336.00 | 4034.00 | -42.09 | 5913.00 | 4820.00 | 22.68 |
| PBIDT | 24613.00 | 9829.00 | 150.41 | 24613.00 | 9829.00 | 150.41 | 48061.00 | 30761.00 | 56.24 |
| Interest | 45.00 | 98.00 | -54.08 | 45.00 | 98.00 | -54.08 | 169.00 | 380.00 | -55.53 |
| PBDT | 24568.00 | 9731.00 | 152.47 | 24568.00 | 9731.00 | 152.47 | 47892.00 | 30381.00 | 57.64 |
| Depreciation | 2372.00 | 2215.00 | 7.09 | 2372.00 | 2215.00 | 7.09 | 9232.00 | 8143.00 | 13.37 |
| PBT | 22196.00 | 7516.00 | 195.32 | 22196.00 | 7516.00 | 195.32 | 38660.00 | 22238.00 | 73.85 |
| TAX | 5802.00 | 2521.00 | 130.15 | 5802.00 | 2521.00 | 130.15 | 12532.00 | 6006.00 | 108.66 |
| Deferred Tax | 415.00 | 1163.00 | -64.32 | 415.00 | 1163.00 | -64.32 | 3891.00 | 2080.00 | 87.07 |
| PAT | 16394.00 | 4995.00 | 228.21 | 16394.00 | 4995.00 | 228.21 | 26128.00 | 16232.00 | 60.97 |
| Equity | 833.00 | 832.00 | 0.12 | 833.00 | 832.00 | 0.12 | 833.00 | 832.00 | 0.12 |
| PBIDTM(%) | 45.27 | 27.07 | 67.21 | 45.27 | 27.07 | 67.21 | 28.33 | 21.35 | 32.69 |
| Company Name | CMP |
|---|---|
| Sun Pharma Inds. | 1872.40 |
| Dr. Reddys Lab | 1279.70 |
| Cipla | 1304.70 |
| Zydus Lifesciences | 956.65 |
| Lupin | 2245.65 |
| View more.. | |
MoneyWorks4Me is a SEBI-registered Investment Adviser (IA) dedicated to helping investors build long-term wealth through transparent, research-driven, conflict-free guidance. Founded in 2008, we started our journey as a Research Analyst (RA), providing deep fundamental analysis, intrinsic value insights, and long-term investing frameworks for Indian equities. In 2017, we transitioned to a full-fledged SEBI-registered Investment Adviser, strengthening our commitment to acting as a fiduciary—always putting the investor’s interest first.
To become India’s most trusted, research-powered fiduciary advisory platform—where every investor, regardless of experience, can make calm, confident, and well-reasoned investment decisions.
MoneyWorks4Me ensures this through: